Skip to content

Effects of a Lay-led Anxiety and Depression Self-management Program for Cancer Patients

Effects on Anxiety and Depression of a Lay-led Transdiagnostic Self-management Program (ADSMP-C) for Patients Recently Treated for Cancer With Curative Intent: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04537195
Acronym
ADSMP-C
Enrollment
234
Registered
2020-09-03
Start date
2020-03-06
Completion date
2026-11-01
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Cancer, Depression, Distress, Emotional, Group, Peer, Neoplasms, Psychological Distress, Self Efficacy

Keywords

Intervention, RCT

Brief summary

The investigators aim to evaluate a peer-to-peer patient self-management program targeting symptoms of anxiety and depression in a randomized trial. A total of 234 cancer patients recently having completed primary treatment with curative intent in central Region Denmark will be included. The intervention is a lay-led, group-based transdiagnostic patient education program consisting of seven 2 ½ hour weekly sessions focusing on increasing patient self-efficacy in symptom management of anxiety and depression. The intervention is highly structured and manualized.

Detailed description

Recent evidence suggest that transdiagnostic interventions may be just as effective as traditional diagnosis specific interventions when treating symptoms of depression and anxiety. Brief lay-led transdiagnostic self-management interventions may therefore offer an efficient alternative to traditional symptom specific interventions (e.g. CBT) when targeting symptoms of depression and anxiety in cancer. The present study aim to evaluate The Anxiety and Depression Symptom Management Program (ADSMP) in a cancer setting (ADSMP-C). The ADSMP is a Danish adaptation of The Stanford University Chronic Disease Self-Management Program (CDSMP) and is developed by the Danish Health Information Committee (In Danish: Komiteen for Sundhedsoplysning in collaboration with The Expert Patient Program Community Interest Company (EPPCIC), the English Health Service (NHS) and Stanford University. The ADSMP-C is a lay-led, group-based transdiagnostic patient education program consisting of seven 2 ½ hour weekly sessions focusing on increasing patient self-efficacy in symptom management of anxiety and depression concluded with a networking session. The intervention is highly structured and manualized. Sub-group analyses on participants with a history of cancer in a larger trial of ADSMP conducted by members of the study group on behalf of the Danish National Board of Health showed promising results. However, a larger study is needed to establish sound scientific evidence on the effectiveness of the program in a cancer setting. A total 234 cancer patients recently having completed primary treatment with curative intent in central Region Denmark will be randomized (2:1) to ADSMP-C or a control arm respectively. As a part of the recruitment procedure patients will be screened with The "Distress-Thermometer" at the departments of oncology at the two largest hospitals in Central Region, Denmark following primary treatment or at a follow-up (\< 1yrs. after primary treatment). Participants completes online questionnaires (REDCap) at baseline (pre-randomization), at post-intervention, and at three (primary follow-up) and six months post-intervention, including the Beck's Depression Inventory (BDI-II) and Spielbergers State-Trait Anxiety Inventory (STAI-state) (primary outcomes). In addition, all participants will be interviewed at 7 month post-intervention. Outcome assessors, blind to group allocation, will perform observer-based Hamilton A6 and D6 short-form ratings at the interview (secondary outcomes). Data will be evaluated by mixed-effects regression analyses (intention-to-treat). The current study will be the first to evaluate the efficacy of ADSMP in a cancer setting.

Interventions

BEHAVIORALADSMP-C

A transdiagnostic, lay-led, group-based self-management program consisting of seven 2 ½ hour weekly sessions focusing on increasing patient self-efficacy in symptom management of anxiety and depression in cancer (ADSMP-C)

Sponsors

University of Aarhus
Lead SponsorOTHER
TrygFonden, Denmark
CollaboratorINDUSTRY
Komiteen for Sundhedsoplysning
CollaboratorUNKNOWN
Aarhus University Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Assessors will be blinded at 7-month follow-up when administering the Hamilton rating scales (secondary outcomes). Participants will be instructed not to disclose their group allocation until the interview is completed

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Treated in Central Region Denmark * Recently completed (\< 1 yr.) primary treatment for cancer with curative intent * BDI-II score \>=14 and/or STAI-state score \>=40

Exclusion criteria

* Not sufficient Danish language skills to fill Questionnaires and participate in a group based intervention * Psychosis * Aggressive behavior * Imminent suicidal risk

Design outcomes

Primary

MeasureTime frameDescription
Change in Depressive SymptomsBaseline and 3 months post-interventionBeck Depression Inventory (BDI-II)
Change in Anxiety SymptomsBaseline and 3 months post-interventionSpielberger State-Trait Inventory (STAI). State subscale.

Secondary

MeasureTime frameDescription
Change in Anxiety SymptomsBaseline and 6 months post-interventionSpielberger State-Trait Inventory (STAI). State subscale.
Change in Depressive SymptomsBaseline and 6 months post-interventionBeck Depression Inventory (BDI-II)
Change in Anxiety (observer-rated)Baseline and 7 months post-interventionHamilton Anxiety Rating Scale (HAM-A6)
Change in Depression (observer-rated)Baseline and 7 months post-interventionHamilton Depression Rating Scale (HAM-D6)
Change in Fear of cancer recurrenceBaseline and 3 months post-interventionConcerns About Recurrence Questionaire (CARQ-4)
Change in Self-efficacy - Personal controlBaseline and 3 months post-interventionThe Revised Illness Perception Questionnaire (IPQ-R). Personal Control subscale.
Change in Self-efficacy - Social supportBaseline, and 3 months post-interventionObtain Help from Community, Family, Friends Scale (SECD-Ssup)

Countries

Denmark

Contacts

PRINCIPAL_INVESTIGATORSoren Christensen, MSc.

Dep. Psychology, Aarhus University, Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026